Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Ingresos
1,021,788
1,013,878
915,139
929,036
853,448
761,321
Crecimiento de los Ingresos (YoY)
2%
11%
-2%
9%
12%
3%
Costo de los ingresos
631,701
618,365
584,280
591,592
551,059
517,872
Utilidad bruta
390,087
395,513
330,859
337,444
302,389
243,449
Venta, General y Administración
153,970
151,835
146,143
144,842
129,625
107,722
Investigación y Desarrollo
47,022
46,771
43,485
40,175
37,271
35,261
Gastos de Operación
209,495
193,928
191,999
187,148
168,276
152,327
Otras Ingresos (Gastos) No Operativos
--
-6
-178
-24
8
36
Ingreso antes de impuestos
181,166
185,329
138,901
146,840
132,378
93,320
Gasto por Impuesto a la Renta
46,865
48,021
36,146
37,576
35,143
23,012
Ingreso Neto
134,251
137,237
102,679
109,173
97,132
70,235
Crecimiento de la Utilidad Neta
3%
34%
-6%
12%
38%
49%
Acciones en Circulación (Diluidas)
674.5
701.44
713.74
739.16
740.33
148.68
Cambio de Acciones (YoY)
-4%
-2%
-3%
0%
398%
-5%
EPS (Diluido)
199.03
195.65
143.86
147.69
131.2
472.38
Crecimiento de EPS
8%
36%
-3%
13%
-72%
56.99%
Flujo de efectivo libre
90,873
111,903
89,667
113,862
85,531
58,585
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
38.17%
39%
36.15%
36.32%
35.43%
31.97%
Margen de operación
17.67%
19.88%
15.17%
16.17%
15.71%
11.96%
Margen de beneficio
13.13%
13.53%
11.22%
11.75%
11.38%
9.22%
Margen de flujo de caja libre
8.89%
11.03%
9.79%
12.25%
10.02%
7.69%
EBITDA
249,524
267,180
199,671
207,658
184,324
139,072
Margen de EBITDA
24.42%
26.35%
21.81%
22.35%
21.59%
18.26%
D&A para EBITDA
68,932
65,595
60,811
57,362
50,211
47,950
EBIT
180,592
201,585
138,860
150,296
134,113
91,122
Margen de EBIT
17.67%
19.88%
15.17%
16.17%
15.71%
11.96%
Tasa de Impuesto Efectiva
25.86%
25.91%
26.02%
25.58%
26.54%
24.65%
Estadísticas clave
Cierre Anterior
$23.55
Precio de apertura
$23.9
Rango del día
$23.9 - $23.9
Rango de 52 semanas
$16.4 - $25.7
Volumen
88
Volumen promedio
41
EPS (TTM)
1.18
Rendimiento de dividendos
--
Cap. de mercado
$16.2B
¿Qué es NDEKF?
Nitto Denko Corp. engages in the manufacture and sale of adhesives, optical films, semiconductors, electronic devices, and consumer products. The company is headquartered in Osaka, Osaka-Fu and currently employs 25,769 full-time employees. The firm operates in three business segments. The Industrial Tapes segment is engaged in the manufacture and sale of basic functional materials such as bonding materials and protective materials, as well as automotive materials. The Optronics segment is engaged in the manufacture and sale of information functional materials, printed circuits and process materials. The Human Life Science segment is engaged in the manufacture and sale of nucleic acid contract manufacturing, nucleic acid synthesis materials, nucleic acid drug discovery, medical-related materials and other life sciences, membranes such as polymer separation membranes, and personal care materials such as functional films for hygiene materials. The firm is also engaged in the manufacture and sale of new businesses and other products.